Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

A.M.E. Schauwvlieghe; G. Dijkman; J.M. Hooymans; F.D. Verbraak; C.B. Hoyng; M.G.W. Dijkgraaf; R. van Leeuwen; J.R. Vingerling; A.C. Moll; R.O. Schlingemann

doi:10.1186/s12886-015-0043-x

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

A.M.E. Schauwvlieghe, G. Dijkman, J.M. Hooymans, F.D. Verbraak, C.B. Hoyng, M.G.W. Dijkgraaf, R. van Leeuwen, J.R. Vingerling, A.C. Moll, R.O. Schlingemann

Ophthalmology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	71
Journal	BMC Ophtalmology
Volume	15
DOIs	https://doi.org/10.1186/s12886-015-0043-x
Publication status	Published - 2015

Access to Document

10.1186/s12886-015-0043-x

Cite this

Schauwvlieghe, A. M. E., Dijkman, G., Hooymans, J. M., Verbraak, F. D., Hoyng, C. B., Dijkgraaf, M. G. W., van Leeuwen, R., Vingerling, J. R., Moll, A. C., & Schlingemann, R. O. (2015). Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study). BMC Ophtalmology, 15, [71]. https://doi.org/10.1186/s12886-015-0043-x

@article{f4371cc38cd44f24beae4a4867305cc3,

title = "Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)",

author = "A.M.E. Schauwvlieghe and G. Dijkman and J.M. Hooymans and F.D. Verbraak and C.B. Hoyng and M.G.W. Dijkgraaf and {van Leeuwen}, R. and J.R. Vingerling and A.C. Moll and R.O. Schlingemann",

year = "2015",

doi = "10.1186/s12886-015-0043-x",

language = "Undefined/Unknown",

volume = "15",

journal = "BMC Ophtalmology",

issn = "1471-2415",

publisher = "BioMed Central",

}

Schauwvlieghe, AME, Dijkman, G, Hooymans, JM, Verbraak, FD, Hoyng, CB, Dijkgraaf, MGW, van Leeuwen, R, Vingerling, JR, Moll, AC & Schlingemann, RO 2015, 'Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)', BMC Ophtalmology, vol. 15, 71. https://doi.org/10.1186/s12886-015-0043-x

TY - JOUR

T1 - Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

AU - Schauwvlieghe, A.M.E.

AU - Dijkman, G.

AU - Hooymans, J.M.

AU - Verbraak, F.D.

AU - Hoyng, C.B.

AU - Dijkgraaf, M.G.W.

AU - van Leeuwen, R.

AU - Vingerling, J.R.

AU - Moll, A.C.

AU - Schlingemann, R.O.

PY - 2015

Y1 - 2015

U2 - 10.1186/s12886-015-0043-x

DO - 10.1186/s12886-015-0043-x

M3 - Article

C2 - 26149170

SN - 1471-2415

VL - 15

JO - BMC Ophtalmology

JF - BMC Ophtalmology

M1 - 71

ER -